Navigating Healthcare Under Trump’s Second Term
Summary
Before taking office for his second term, Donald Trump made clear that his administration had plans to overhaul federal health programs, slash costs, and reduce regulations. Efforts are underway to restructure Medicaid, roll back key provisions of the Affordable Care Act (ACA), and reshape the nation’s approach to public health and pandemic response. While Republicans hold majorities in both the House and Senate, their slim advantage means passing these reforms is far from certain. Supporters of Trump’s healthcare agenda argue that cutting federal oversight will drive down costs and improve efficiency, while critics warn that such changes could disproportionately affect low-income Americans, increase the uninsured rate, and place additional strain on hospitals and providers.
Central to this debate is Medicaid reform, which Trump and Congressional Republicans have framed as a cost-cutting measure to balance federal spending. While Congress may very well cut federal spending might be cut, recent reports suggest that significant cuts to Medicaid could force states to make tough decisions on eligibility, benefits, and provider payments—potentially jeopardizing healthcare for millions of Americans. Recent discussions among House Republicans indicate internal divisions over the extent of Medicaid reductions, with some lawmakers warning that deep cuts could result in voter backlash, particularly in states with high Medicaid enrollment. The budget resolution's passage is a crucial step for Republicans to advance Trump’s legislative agenda, but it also highlights the challenges ahead, including debates on protecting key social programs and ensuring the plan doesn't add to the nation's $36 trillion debt.
Additionally, Trump has revived efforts to repeal and replace the ACA without providing a clear replacement plan, leaving many in Congress skeptical of the feasibility of a full repeal. Meanwhile, his administration has prioritized short-term, limited-duration health plans, which offer lower-cost coverage but lack many of the consumer protections required under the ACA.
In a narrow 217-215 vote on February 25, 2025, the House of Representatives passed a budget resolution central to Trump’s healthcare agenda, proposing $2 trillion in spending cuts over the next decade while allocating up to $4.5 trillion for tax cuts. The Senate approved its own version on February 21, 2025, by a 52-48 margin, setting up negotiations to reconcile differences between the two. Given the slim Republican majority and internal divisions over spending cuts and tax reforms, passing a unified proposal remains uncertain, with intense negotiations expected to determine its final outcome.
What Could Change
Beyond Medicaid and ACA rollbacks, Trump’s second-term healthcare agenda includes:
Reshaping Medicaid through block grants and per capita caps, shifting costs to states.
Cutting funding for public health programs, including those related to pandemic preparedness and opioid treatment.
Expanding association health plans and short-term insurance options, which critics argue undermine ACA consumer protections.
Reducing regulations on pharmaceutical pricing, though details on how this would be achieved remain vague.
Shifting pandemic response strategies to downplay government intervention in public health crises.
Slashing federal staffing at key agencies, including HHS, the FDA, CDC, and NIH, reduces regulatory oversight and slows down drug and medical research approval processes.
Knowledge Base
Block Grants: Block grants provide fixed sums to states, and could limit the funding available for Medicaid, leading to difficult decisions about eligibility and services.
Association Health Plans: Association health plans are a form of health insurance that allows small businesses to pool resources, but critics argue they lack critical consumer protections.
Per Capita Caps: A limit on how much the federal government will pay for each Medicaid enrollee.
In Context
-
One of the most immediate and disruptive effects of Trump’s second-term agenda will be ongoing disputes over Medicaid reductions. Reports from congressional negotiations suggest that while some Republicans are pushing for deep Medicaid cuts as part of budget negotiations, others are increasingly wary of the political consequences. Some GOP lawmakers have voiced concerns that aggressive Medicaid restructuring, including work requirements and budget caps, could alienate voters in swing states. The uncertainty surrounding these negotiations makes Medicaid one of the most volatile policy areas in the current administration's healthcare approach.
Additionally, while Trump recently reassured voters that Medicaid would not be touched, he subsequently endorsed a House Republican budget plan that includes significant cuts, creating confusion among stakeholders and legislators. The administration's lack of a clear stance on Medicaid policy has further fueled uncertainty in the healthcare sector.
-
While Republicans hold majorities in both chambers, passing sweeping healthcare reforms will be challenging. Moderate Republicans may hesitate to support drastic Medicaid cuts, especially those from swing states with high enrollment numbers. Additionally, any attempt to repeal ACA provisions will likely face resistance, particularly in the Senate.
As of last week, Congressional negotiations on Medicaid reforms are ongoing, with some Republicans pushing for a more measured approach. The March 14, 2025, budget deadline will serve as a critical test for whether the administration can advance its healthcare agenda before funding debates take center stage.
Impact on Research & the Greater Philadelphia Region
-
Pennsylvania’s Medicaid expansion under the ACA covers over 3 million residents. Proposed federal cuts could force Governor Shapiro’s administration to make tough decisions on coverage eligibility and provider reimbursements. Additionally, Pennsylvania’s hospital network, which is already contending with daunting challenges, especially in rural areas, could face significant financial strain if Medicaid funding is reduced.
-
Philadelphia has one of the highest Medicaid enrollment rates among major U.S. cities, meaning any federal cuts would directly impact residents. The city would need to explore alternative funding sources to maintain coverage levels, particularly for low-income families and vulnerable populations.
Moreover, public health funding reductions could affect programs related to mental health services, pandemic preparedness, and community health centers, shifting more responsibility to local agencies and nonprofit organizations.
As the Greater Philadelphia Chamber of Commerce recently outlined, one significant example of these challenges is the recent implementation of a 15% cap on Facility & Administrative (or "F&A") costs for all new and existing National Institutes of Health (NIH) grants. This policy change has significant implications for our region. (Via Chamber of Commerce)
Pennsylvania could see more than $367 million in annual losses, impacting universities, hospitals, and research institutions.
The financial strain could have long-term consequences in Greater Philadelphia, where anchor institutions supported nearly 496,000 jobs and contributed over $51 billion to regional GDP in 2019.
Losses in funding could reduce support for startups, small businesses, and life sciences innovation, limiting job opportunities and slowing the development of new medical treatments.
For Pennsylvania’s rural hospitals, which already face significant financial strain, reductions in Medicaid funding could lead to service cuts or, in severe cases, potential closures.
-
Hospitals & Providers: Medicaid cuts could lead to lower reimbursements, particularly impacting rural hospitals.
Pharmaceutical Industry: Regulatory rollbacks could increase innovation but also raise drug prices.
State Governments: Greater Medicaid flexibility could result in coverage gaps if funding is insufficient.
Employers & Insurance Markets: Changes to health insurance plans could alter employee coverage options for employees.
Researchers: Cuts to scientific research funding could hinder medical advancements and limit the development of innovative treatments.
Key Appointments Influencing Healthcare Policy
President Trump's recent appointments are poised to influence healthcare policy significantly:
Robert F. Kennedy Jr.: Approved as Secretary of Health and Human Services (HHS) on February 20, 2025, Kennedy is known for his skepticism toward vaccines and pharmaceutical companies. His advocacy for overhauling the FDA and CDC aligns with the administration's goal of reducing government intervention in healthcare but raises concerns about vaccine policies and public health initiatives.
Dr. Mehmet Oz: Nominated to lead the Centers for Medicare and Medicaid Services (CMS), Dr. Oz is a heart surgeon and former television host. His nomination requires Senate confirmation, and he has begun meeting with senators to garner support. If confirmed, Dr. Oz will oversee Medicaid, Medicare, and the Affordable Care Act, which provide health insurance for millions of Americans.
Looking Ahead
The Trump administration’s healthcare proposals could lead to significant changes in Medicaid, insurance regulations, and public health policy. While some reforms may increase flexibility and reduce federal spending, they also carry risks—particularly for low-income individuals, healthcare providers, and state governments. As Congress continues to debate the future of Medicaid and other key health programs, it remains to be seen whether the administration will be able to navigate the political complexities they’ll face when enacting their reforms, or whether Congressional approval and public outcry will stand in their way.
Contributors
Read More
